Literature DB >> 25728318

A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies.

Susheel K Singh1, Will Roeffen2, Gorm Andersen3, Teun Bousema4, Michael Christiansen5, Robert Sauerwein2, Michael Theisen6.   

Abstract

The sexual stage Pfs48/45 antigen is a well-established lead candidate for a transmission blocking (TB) vaccine because of its critical role in parasite fertilization. We have recently produced the carboxy-terminal 10C-fragment of Pfs48/45 containing three known epitopes for TB antibodies as a chimera with the N-terminal region of GLURP (R0). The resulting fusion protein elicited high titer TB antibodies in rodents. To increase the relatively low yield of correctly folded Pfs48/45 we have generated a series of novel chimera truncating the 10C-fragments to 6 cysteine residues containing sub-units (6C). All constructs harbor the major epitope I for TB antibodies. One of these sub-units (R0.6Cc), produced high yields of correctly folded conformers, which could be purified by a simple 2-step procedure. Purified R0.6Cc was stable and elicits high titer TB antibodies in rats. The yield, purity and stability of R0.6Cc allows for further clinical development.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GLURP; Pfs48/45; Plasmodium falciparum; SMFA; Transmission blocking

Mesh:

Substances:

Year:  2015        PMID: 25728318     DOI: 10.1016/j.vaccine.2015.02.040

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  31 in total

Review 1.  Transmission-Blocking Vaccines: Old Friends and New Prospects.

Authors:  Festus K Acquah; Joshua Adjah; Kim C Williamson; Linda E Amoah
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

Review 2.  The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle.

Authors:  Silvia A Arredondo; Stefan H I Kappe
Journal:  Int J Parasitol       Date:  2016-11-27       Impact factor: 3.981

3.  Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite.

Authors:  Ulrik H Mistarz; Susheel K Singh; Tam T T N Nguyen; Will Roeffen; Fen Yang; Casper Lissau; Søren M Madsen; Astrid Vrang; Régis W Tiendrebeogo; Ikhlaq H Kana; Robert W Sauerwein; Michael Theisen; Kasper D Rand
Journal:  Pharm Res       Date:  2017-06-23       Impact factor: 4.200

4.  Method for Production of Cysteine-Rich Proteins in Lactococcus lactis Expression System.

Authors:  Susheel K Singh; Vandana Singh
Journal:  Methods Mol Biol       Date:  2022

5.  Heterologous Expression and Evaluation of Novel Plasmodium falciparum Transmission Blocking Vaccine Candidates.

Authors:  Roos M de Jong; Susheel K Singh; Karina Teelen; Marga van de Vegte-Bolmer; Geert-Jan van Gemert; Will J R Stone; Emily Locke; Jordan Plieskatt; Michael Theisen; Teun Bousema; Matthijs M Jore
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

Review 6.  Plasmodium falciparum gametocyte transit through the cutaneous microvasculature: A new target for malaria transmission blocking vaccines?

Authors:  Christian P Nixon
Journal:  Hum Vaccin Immunother       Date:  2016-05-16       Impact factor: 3.452

7.  A Global Survey of ATPase Activity in Plasmodium falciparum Asexual Blood Stages and Gametocytes.

Authors:  Corrie Ortega; Andrew Frando; Bobbie-Jo Webb-Robertson; Lindsey N Anderson; Neil Fleck; Erika L Flannery; Matthew Fishbaugher; Taylor A Murphree; Joshua R Hansen; Richard D Smith; Stefan H I Kappe; Aaron T Wright; Christoph Grundner
Journal:  Mol Cell Proteomics       Date:  2017-10-27       Impact factor: 5.911

8.  The Plasmodium falciparum circumsporozoite protein produced in Lactococcus lactis is pure and stable.

Authors:  Susheel K Singh; Jordan Plieskatt; Bishwanath Kumar Chourasia; Vandana Singh; Judith M Bolscher; Koen J Dechering; Bright Adu; Blanca López-Méndez; Swarnendu Kaviraj; Emily Locke; C Richter King; Michael Theisen
Journal:  J Biol Chem       Date:  2019-12-02       Impact factor: 5.157

9.  Immunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross-Boosting of Immune Responses.

Authors:  Yi Cao; Geetha P Bansal; Kristen Merino; Nirbhay Kumar
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

Review 10.  Recent advances in recombinant protein-based malaria vaccines.

Authors:  Simon J Draper; Evelina Angov; Toshihiro Horii; Louis H Miller; Prakash Srinivasan; Michael Theisen; Sumi Biswas
Journal:  Vaccine       Date:  2015-10-11       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.